Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion evidence source_evidence_literature NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion SIO_000772 22334453 NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion wasDerivedFrom befree-20140225 NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion wasGeneratedBy ECO_0000203 NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.